|
US4451447A
(en)
*
|
1980-03-31 |
1984-05-29 |
Bristol-Myers Company |
Pharmaceutical formulations
|
|
US4981692A
(en)
*
|
1983-03-24 |
1991-01-01 |
The Liposome Company, Inc. |
Therapeutic treatment by intramammary infusion
|
|
US4590001A
(en)
*
|
1983-03-28 |
1986-05-20 |
Stjernholm Rune L |
Platinum bound to transferrin for use in the treatment of breast tumors
|
|
USRE33071E
(en)
*
|
1983-03-28 |
1989-09-26 |
|
Platinum bound to transferrin for use in the treatment of breast tumors
|
|
US5019369A
(en)
*
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
JPH0665648B2
(ja)
*
|
1985-09-25 |
1994-08-24 |
塩野義製薬株式会社 |
白金系抗癌物質の安定な凍結真空乾燥製剤
|
|
US5041581A
(en)
*
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5117022A
(en)
*
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5049388A
(en)
*
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
|
US5320906A
(en)
*
|
1986-12-15 |
1994-06-14 |
Vestar, Inc. |
Delivery vehicles with amphiphile-associated active ingredient
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
IL83380A
(en)
*
|
1987-07-30 |
1991-04-15 |
Teva Pharma |
Stable aqueous cisplatin solutions
|
|
DE68901733T2
(de)
*
|
1988-03-04 |
1993-03-25 |
Takeda Chemical Industries Ltd |
Liposom-zusammensetzung.
|
|
US5141751A
(en)
*
|
1988-06-29 |
1992-08-25 |
Daiichi Pharmaceutical Co., Ltd. |
Lipid membrane structures
|
|
US5549910A
(en)
*
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5225212A
(en)
*
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
US5747469A
(en)
*
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
JP3220180B2
(ja)
*
|
1991-05-23 |
2001-10-22 |
三菱化学株式会社 |
薬剤含有タンパク質結合リポソーム
|
|
US5756353A
(en)
*
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
US5858784A
(en)
*
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5958449A
(en)
*
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
|
US5665383A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5780054A
(en)
*
|
1996-01-17 |
1998-07-14 |
University Of British Columbia |
Methods for increasing the circulation half-life of protein-based therapeutics
|
|
AU2230497A
(en)
*
|
1996-02-26 |
1997-09-10 |
Daiichi Pharmaceutical Co., Ltd. |
Liposome and liposome dispersion
|
|
ES2201296T3
(es)
*
|
1996-04-26 |
2004-03-16 |
Genaera Corporation |
Escualmina en combinacion con otros farmacos anticancerigenos para el tratamiento de tumores.
|
|
CA2263455C
(en)
*
|
1996-08-23 |
2002-10-29 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
|
US5997899A
(en)
*
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
|
EP0954283B1
(en)
*
|
1996-12-30 |
2007-03-21 |
Battelle Memorial Institute |
Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
|
|
US6451784B1
(en)
*
|
1996-12-30 |
2002-09-17 |
Battellepharma, Inc. |
Formulation and method for treating neoplasms by inhalation
|
|
US6630168B1
(en)
*
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
|
US6090407A
(en)
*
|
1997-09-23 |
2000-07-18 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anti-cancer drugs
|
|
US6787132B1
(en)
*
|
1997-12-04 |
2004-09-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combined chemo-immunotherapy with liposomal drugs and cytokines
|
|
US6726925B1
(en)
*
|
1998-06-18 |
2004-04-27 |
Duke University |
Temperature-sensitive liposomal formulation
|
|
CA2248592A1
(en)
*
|
1998-08-31 |
2000-02-29 |
Christopher D. Batich |
Microspheres for use in the treatment of cancer
|
|
ES2156506B1
(es)
*
|
1998-10-14 |
2002-03-01 |
Sumitomo Chemical Co |
Metodo para la produccion de oxido de propileno.
|
|
US20050074499A1
(en)
*
|
1999-03-17 |
2005-04-07 |
Mitsubishi Chemical Corporation |
Ligand-bonded complex
|
|
US7244448B2
(en)
*
|
2000-06-30 |
2007-07-17 |
Tekmira Pharmaceuticals Corporation |
Liposomal antineoplastic drugs and uses thereof
|
|
US6723338B1
(en)
*
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
|
US6852334B1
(en)
*
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
JP2003503313A
(ja)
*
|
1999-06-03 |
2003-01-28 |
ジェシー エル エス オウ |
細胞増殖及び細胞死を変調する方法及び組成物
|
|
US6352996B1
(en)
*
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
|
US6800437B1
(en)
*
|
1999-08-06 |
2004-10-05 |
Tibotec Bvba |
Method of monitoring a biological system by labeling with an apo metal binding protein
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
KR100799089B1
(ko)
*
|
1999-12-04 |
2008-01-29 |
리서치 디벨럽먼트 파운데이션 |
에어로졸화된 약물의 침착 증진 조성물
|
|
JP4786105B2
(ja)
*
|
2000-02-04 |
2011-10-05 |
リポクセン テクノロジーズ リミテッド |
リポソーム
|
|
AU2001260270A1
(en)
*
|
2000-05-02 |
2001-11-12 |
Pharmacept Gmbh |
Liposomes containing active substances
|
|
US6989156B2
(en)
*
|
2001-04-23 |
2006-01-24 |
Nucryst Pharmaceuticals Corp. |
Therapeutic treatments using the direct application of antimicrobial metal compositions
|
|
WO2002060412A2
(en)
*
|
2001-02-01 |
2002-08-08 |
Board Of Regents |
Stabilised polymeric aerosols for pulmonary gene delivery
|
|
PT1320355E
(pt)
*
|
2001-05-18 |
2006-08-31 |
Chiron Corp |
Sistema para administracao de uma formulacao de tobramicina
|
|
US7063860B2
(en)
*
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
CA2457148A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
JP2005502653A
(ja)
*
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
|
US20040022842A1
(en)
*
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
JP3415131B1
(ja)
*
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
JP2006502233A
(ja)
*
|
2002-08-02 |
2006-01-19 |
トランセーブ，インク． |
白金凝集物およびその製造方法
|
|
JP4874547B2
(ja)
*
|
2002-11-26 |
2012-02-15 |
ギリアード サイエンシーズ， インコーポレイテッド |
勾配によるリポソームへの薬物充填方法
|